checkAd

Bittium Corporation -- interessanter Wert (Seite 3)

eröffnet am 27.02.18 08:03:31 von
neuester Beitrag 30.06.20 13:10:25 von

ISIN: FI0009007264 | WKN: 916295
6,285
18:31:47
Lang & Schwarz
-1,18 %
-0,075 EUR

Beitrag zu dieser Diskussion schreiben


  • 1
  • 3

Begriffe und/oder Benutzer

 

Fragen

 Ja Nein
Avatar
03.04.18 09:24:52
Beitrag Nr. 8 ()
Free for publication on March 28, 2018 at 4.45pm (CEST +1)

Bittium expands its medical remote diagnostics offering by acquiring RemoteA’s medical remote diagnostics service platform

With the business transaction Bittium’s offering expands from measuring and monitoring the electrical activity of the heart and brain to measuring and monitoring sleep apnea

Oulu, Finland, March 28, 2018 – Bittium Medanalytics Oy, a subsidiary of Bittium Corporation, and RemoteA Oy have today signed a business purchase agreement according to which Bittium Medanalytics Oy purchases RemoteA’s medical remote diagnostic service platform and the product rights of the related medical measurement devices and their interfaces. With the business transaction Bittium’s offering expands from measuring and monitoring the electrical activity of the heart and brain to measuring and monitoring sleep apnea. In addition, a third party blood pressure measurement device has been connected to the service platform, and in the future, it is possible to connect also other measurement devices to the system. Biosignal information collected from the patients via the remote diagnostics service platform enables the transfer of information over the internet and it serves as a platform for patient measurement data and specialists’ diagnosis.

”After completing the business transaction, Bittium is able to deliver its customers offering remote diagnostics services a complete solution for long-term recordings of ECG, blood pressure and sleep apnea, as well as measurement and information transfer services over the internet. Bittium’s complete solution includes biosignal measurement and analysis software, and enables patient’s measurement information and medical diagnosis information over the internet and thus facilitates and speeds up patient care. This business transaction expands our offering in the Medical Technologies product and service area and supports Bittium’s strategic goal to grow as a solution provider for biosignal measurements”, says Hannu Huttunen, CEO of Bittium Corporation.

RemoteA and Bittium have earlier both been providing Coronaria Analyysipalvelut Oy, a joint venture of Bittium and Coronaria, with measurement and remote diagnosis information transfer services which, after this business transaction, will be transferred to Bittium’s sole responsibility. Bittium will provide similar service and the measuring equipment needed in the future also to RemoteA’s subsidiary in Sweden.

The business transaction has no significant impact on Bittium Corporation’s financial outlook for 2018. The parties have agreed that the value of the transaction will not be published.
Avatar
12.03.18 09:26:21
Beitrag Nr. 7 ()
Free for release on March 12, 2018 at 10am (CET +1)

Bittium exhibits its innovative R&D services for IoT; and medical technology products at Wearable Technology Show 2018 in London

Bittium’s presentation discusses about medical remote monitoring in the 5G era

Oulu, Finland, March 12, 2018 – Bittium exhibits its innovative R&D services for IoT (Internet of Things); and medical technology products at Wearable Technology Show 2018, to be held in ExCel, London, the United Kingdom on March 13–14, 2017. Bittium’s strong competence in medical grade R&D services, wireless devices, digitalization and information security enable us to create solutions which bring clear added value to both healthcare workers and patients.

At the event Bittium has a speaking slot in the Digital health technology track: "Medical remote monitoring in the 5G era”. Remote medical monitoring is one of the fastest growing medical device and service segments in the world. What does 5G connectivity bring in to the equation? The speaker is Pekka Pirttiaho, Sales Director of Medical Technology product and service area. Bittium is also participating in a discussion panel about ”AI – taking healthcare to another level”. The panel of experts will discuss about what kind of problems are possible to solve with the help of artificial intelligence regarding to patients, hospitals, and the healthcare industry in general, and what is on the horizon. Bittium’s panelist is AI Specialist Vili Kellokumpu
Avatar
10.03.18 08:36:16
Beitrag Nr. 6 ()
Bittium Cardiac Navigator software solution for the analysis of the electrical cardiac activity Holter recordings received medical device approval in Europe
Oulu, Finland, March 9, 2018 – Bittium Cardiac Navigator™ meant for the analysis of clinical Holter ECG recordings has received medical device approval in Europe. The approval allows cardiologists to use the Bittium Cardiac Navigator software solution for official analysis of Holter-ECG recordings collected with Bittium Faros ECG monitoring devices.

The user-friendly and informative ECG data presentation and intuitive analysis tools of Bittium Cardiac Navigator software solutions make the software efficient and easy to use when analyzing multiple days of ECG recordings. Based on recordings, the software provides information about the electrical cardiac activity of the heart, typical of Holter ECG analysis, and in particular, about arrhythmia and other exceptional events. Bittium Cardiac Navigator is designed for scanning longer measurements efficiently in a shorter time and thus speeding up the final diagnosis.

Bittium Faros product family and Bittium Cardiac Navigator software solution

Bittium Faros is a versatile ECG device that is used for early detection of cardiac abnormalities in everyday life. Bittium Faros is ultra-small and lightweight, which enables precise long-term full disclosure ECG measurements for long-term Holtering, cardiac event monitoring, mobile cardiac telemetry and assessing autonomic nervous system functions.

Bittium Faros outpatient monitoring solutions include several software options for cardiac monitoring. The built-in arrhythmia detection algorithms of the Bittium Faros device are used for event recording and mobile event monitoring. This technology enables earlier repatriation of patients and even better ability to react to potentially emerging arrhythmias faster.

Bittium Cardiac Navigator is a completely new type of solution for the analysis of clinical Holter ECG recordings. Its user-friendly and informative data presentation and intuitive analysis tools make the software efficient and easy to use when analyzing multiple days of ECG recordings. Bittium Cardiac Navigator is designed for scanning longer measurements efficiently in a shorter time and thus speeding up the final diagnosis.

More information on the offering: https://www.bittium.com/products__services/medical/bittium_f…
Avatar
10.03.18 08:30:16
Beitrag Nr. 5 ()
Bittium Corporation is a Finnish company headquartered in Oulu.

Bittium is an engineering company in Wireless businesses. Bittium specializes in the development of secure communications and connectivity solutions.

The company's customer segments include the telecommunications, Internet of Things, and defense industries.

On 28 January 2013 Anite plc of the U.K. announced it would acquire the Elektrobit System Test Ltd. subsidiary from Elektrobit Corporation (EB), representing the Propsim portion of EB's business. The acquisition was effective 1 February 2013. [1]

On May 19, 2015, Elektrobit announced the sale of its automotive business segment to Continental AG for $680 million USD.[2] The sale includes the Elektrobit brand and all automotive segment assets. Elektrobit's wireless business will be renamed Bittium Corporation. The acquisition was effective 1 July 2015. [3]

On November 10, 2016, Bittium announced the acquisition of Mega Electronics Ltd and MegaKoto Ltd, Finnish companies based in Kuopio. Mega Electronics Ltd, founded in 1983, is an ISO13485 certified medical device manufacturing company. The company is specialized in biosignal measuring for cardiology, neurology, rehabilitation, occupational health and sports medicine. MegaKoto Ltd provides arrhythmia monitoring services for its customers such as primary care centers, private clinics and hospitals
Avatar
28.02.18 15:46:34
Beitrag Nr. 4 ()
Bittium starts volume deliveries of mobile devices developed for Mexican government authorities
New branch office established in Mexico will support customers in Mexico and Latin America

Oulu, Finland, January 18, 2018 – Bittium has received the first orders from Mexican government authorities for mobile devices developed for a satellite communication system. The mobile devices have been developed in a product development project that started in the year 2015. The product development phase has been successfully concluded and the devices are now in volume production. The total value of the first orders is approximately 2 million euros and the devices will be delivered to the customers by the end of the first quarter of 2018. The mobile devices are manufactured in Finland.

Bittium has opened a branch office in Mexico to enable high quality customer support for the local customers, and to contribute to sales and marketing in Mexico and other Latin American countries. Mr. Fernando Castillo has been appointed as the General Manager of the branch office in Mexico. Mr. Castillo has long experience from the Mexican authorities market.

“These first volume orders for the new mobile devices are continuation to a successful product development phase and good cooperation with the Mexican authorities. These are the most advanced hybrid devices in the world developed for a satellite communication system, which can be used for communication in both the satellite and terrestrial networks. In addition to high quality products, we want to offer our customers in Mexico high quality support and local services. Our presence in Mexico will also give us better visibility to the whole Latin American market”, says Mr. Hannu Huttunen, CEO of Bittium.

In addition to the branch office in Mexico, Bittium has sales and customer support activities in the United Kingdom, Singapore and USA. Bittium currently employs altogether over 600 employees worldwide.
Avatar
28.02.18 15:44:57
Beitrag Nr. 3 ()
Bittium Biosignals Ltd, subsidiary of Bittium Corporation, has signed a supply agreement to deliver customized ECG monitoring devices to a major US remote monitoring company
Bittium Biosignals Ltd, a subsidiary of Bittium Corporation, and a major US remote monitoring provider, have concluded a three-year supply agreement under which Bittium will supply the Bittium Faros™ 360 and customized Bittium Faros™ 360 cardiac ECG signal measuring and monitoring devices. In addition, Bittium will supply disposable electrodes for attaching Bittium Faros ECG devices.

When materialized in full, the total value of the agreement is USD 21 million (approximately EUR 17,1 million based on an exchange rate of February 12, 2018) with revenues recognized gradually during the years 2018, 2019, 2020 and 2021 depending on the progress of the product deliveries, with estimated emphasis on 2019 and 2020. This agreement does not change the Company’s long term financial outlook (published in the Half Year Financial Report January-June 2017 on August 9, 2017). Bittium will publish its Financial Statement Bulletin 2017 on February 22, 2018, where the Company will release the Financial Outlook for 2018.

The agreement, including product customization work, contains terms and conditions that are typical for supply agreements such as schedule and quality requirements. In addition the agreement enables development cooperation between the parties. The Bittium Faros 360 has U.S. FDA regulatory approval and according to the agreement Bittium is responsible for FDA approval of the customized Bittium Faros 360 device. The agreement terms include exclusive distribution rights for the Bittium Faros 360 devices for ambulatory ECG monitoring services in the U.S.A.

”The agreement is a very important expansion for Bittium in the competitive and growing healthcare technology export market. Bittium has the potential to grow into a major manufacturer and supplier for ambulatory ECG monitoring devices in the U.S.,” says Hannu Huttunen, CEO of Bittium Corporation.

The Bittium Faros 360 is a versatile ECG device that is used for early detection of cardiac abnormalities in everyday life. The Bittium Faros is ultra-small and lightweight and enables precise, long-term full disclosure ECG measurements and recordings, monitoring abnormal cardiac events, and mobile cardiac telemetry.

Oulu, February 13, 2018

Hannu Huttunen
CEO
Bittium Corporation
Avatar
27.02.18 19:42:21
Beitrag Nr. 2 ()
Lesezeichen...
Avatar
27.02.18 08:03:31
Beitrag Nr. 1 ()
Habe erstmals von dem Wert gelesen, hört sich gut an, besonders die Medizintechsparte
  • 1
  • 3
 DurchsuchenBeitrag schreiben


Bittium Corporation -- interessanter Wert